<SEC-DOCUMENT>0001047469-16-012401-index.html : 20160421 <SEC-HEADER>0001047469-16-012401.hdr.sgml : 20160421 <ACCEPTANCE-DATETIME>20160421080316 ACCESSION NUMBER: 0001047469-16-012401 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20160608 FILED AS OF DATE: 20160421 DATE AS OF CHANGE: 20160421 EFFECTIVENESS DATE: 20160421 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 161582653 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>DEF 14A <SEQUENCE>1 <FILENAME>a2228333zdef14a.htm <DESCRIPTION>DEF 14A <TEXT> Document 1 - file: a2228333zdef14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>g22932bei001.gif <DESCRIPTION>G22932BEI001.GIF <TEXT> Document 2 - file: g22932bei001.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>g22932bei002.gif <DESCRIPTION>G22932BEI002.GIF <TEXT> Document 3 - file: g22932bei002.gif
</DOCUMENT> </SEC-DOCUMENT>